CVR Q3 2023 Earnings Narrowing Loss Amid Stable Operations
Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings EPS Beat Narrowed Net Loss No Revenue Reported
ESAB Q1 2026 Earnings EPS Slightly Misses Expectations Amid Steady Execution
SOPA Q3 2025 Earnings EPS Falls Far Below Estimates Revenue Not Disclosed
OXLC Q4 2025 Earnings EPS Misses Estimates as Net Investment Income Falls Short
SNTI Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline in PreRevenue Phase